Article thumbnail

Protection against Bronchiolitis Obliterans Syndrome Is Associated with Allograft CCR7+CD45RA− T Regulatory Cells

By Aric L. Gregson, Aki Hoji, Vyacheslav Palchevskiy, Scott Hu, S. Samuel Weigt, Eileen Liao, Ariss Derhovanessian, Rajeev Saggar, Sophie Song, Robert Elashoff, Otto O. Yang and John A. Belperio


Bronchiolitis obliterans syndrome (BOS) is the major obstacle to long-term survival after lung transplantation, yet markers for early detection and intervention are currently lacking. Given the role of regulatory T cells (Treg) in modulation of immunity, we hypothesized that frequencies of Treg in bronchoalveolar lavage fluid (BALF) after lung transplantation would predict subsequent development of BOS. Seventy BALF specimens obtained from 47 lung transplant recipients were analyzed for Treg lymphocyte subsets by flow cytometry, in parallel with ELISA measurements of chemokines. Allograft biopsy tissue was stained for chemokines of interest. Treg were essentially all CD45RA−, and total Treg frequency did not correlate to BOS outcome. The majority of Treg were CCR4+ and CD103− and neither of these subsets correlated to risk for BOS. In contrast, higher percentages of CCR7+ Treg correlated to reduced risk of BOS. Additionally, the CCR7 ligand CCL21 correlated with CCR7+ Treg frequency and inversely with BOS. Higher frequencies of CCR7+ CD3+CD4+CD25hiFoxp3+CD45RA− lymphocytes in lung allografts is associated with protection against subsequent development of BOS, suggesting that this subset of putative Treg may down-modulate alloimmunity. CCL21 may be pivotal for the recruitment of this distinct subset to the lung allograft and thereby decrease the risk for chronic rejection

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1987). A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes.
  2. (1996). Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis.
  3. (2008). Altered levels of CC chemokines during pulmonary CMV predict BOS and mortality post-lung transplantation.
  4. (2007). Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation.
  5. (2004). Bioconductor: Open software development for computational biology and bioinformatics. Genome Biology 5: R80. Available at http://genomebiology. com/2004/5/10/R80 (last accessed
  6. (2006). Bronchiolitis obliterans following lung transplantation.
  7. (2002). Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria.
  8. (2005). CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: Antigen-specific reactivation in vivo is critical for bystander regulation.
  9. (2006). CD4+25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation.
  10. (2001). CD4+CD25high regulatory cells in human peripheral blood.
  11. (2008). Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level.
  12. (2008). Coordination of early protective immunity to viral infection by regulatory T cells.
  13. (2009). Core Team
  14. (2005). Critical influence of natural regulatory CD25+ T cells on the fate of allografts in the absence of immunosuppression.
  15. (1996). Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation–early risk factors.
  16. (2004). Developmental stage, phenotype, and migration distinguish naive- and effector/ memory-like CD4+ regulatory T cells.
  17. (2003). Differential expression of Smad7 transcripts identifies the CD4+CD45RChigh regulatory T cells that mediate type V collagen-induced tolerance to lung allografts.
  18. (2007). Distinctive role of CCR7 in migration and functional activity of naive- and effector/memory-like treg subsets.
  19. (2007). Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection.
  20. (2006). Expression of CD103 identifies human regulatory T-cell subsets.
  21. (2002). Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes.
  22. (2002). Expression of the integrin alpha ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells.
  23. (2010). flowCore: Basic structures for flow cytometry data. Available at http://www.bioconductor. org/packages/2.6/bioc/html/flowCore.html (last accessed
  24. (2003). Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation.
  25. (2002). Identification of regulatory T cells in tolerated allografts.
  26. (2005). Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation.
  27. (2007). Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
  28. (2004). Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants.
  29. (2009). Lattice: Lattice graphics. Available at http://CRAN.R-project. org/package=lattice (last accessed
  30. (2007). Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome.
  31. (2005). Lung transplantation: Opportunities for research and clinical advancement.
  32. (2005). Migration matters: Regulatory T-cell compartmentalization determines suppressive activity in vivo.
  33. (2005). Minimal acute rejection after lung transplantation: A risk for bronchiolitis obliterans syndrome.
  34. (2006). Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.
  35. (2004). New approaches to fluorescence compensation and visualization of FACS data. Clin Immunol 110(3): 277–283. 2 4 . K a oJ ,K o b a s h i g a w aJ ,F i s h b e i nM
  36. (1995). Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. washington university lung transplant group.
  37. (2005). Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor.
  38. (2007). Registry of the international society for heart and lung transplantation: Twentyfourth official adult lung and heart-lung transplantation report-2007.
  39. (2006). Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells.
  40. (2003). Regulatory CD8+CD282 T cells in heart transplant recipients.
  41. (2008). Regulatory T cells and immune tolerance.
  42. (2009). Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response.
  43. (2005). Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome.
  44. (2003). Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells.
  45. (1995). The cost-effectiveness of lung transplantation. A pilot study: University of Washington medical center lung transplant study group.
  46. (2005). The effect of primary graft dysfunction on survival after lung transplantation.
  47. (2005). The significance of a single episode of minimal acute rejection after lung transplantation.
  48. (2010). with contributions from many other users (2009) Hmisc: Harrell miscellaneous. Available at (last accessed